Contemporary Management of PE Patients in SHOCK-AC/Lytics/CBL/Thrombectomy: When to Do What

AC/Lytics/CBL/Thrombectomy: When to Do What

Video Transcription

Video Summary

The lecture discusses the management of acute pulmonary embolism (PE), focusing on risk stratification and treatment options. Low-risk PE typically involves anticoagulation alone. Intermediate-risk cases also generally use anticoagulation, despite some trials showing reduced mortality with thrombolytics. However, thrombolytics increase bleeding risks, including intracranial hemorrhage, leading to their limited use in intermediate-risk PE. High-risk, hemodynamically unstable patients are typically treated with systemic thrombolytics or advanced therapies like catheter-directed thrombolysis, though mechanical thrombectomy is gaining favor for its lytic-free approach. Ongoing trials aim to provide more definitive data for treatment efficacy.

Asset Subtitle

Sripal Bangalore, MD, MHA, FSCAI

Keywords

pulmonary embolism

risk stratification

anticoagulation

thrombolytics

thrombectomy